Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Rebecca Torrence"


25 mentions found


Now 42, Bilimoria is the sole partner of Refactor Capital, the early-stage venture-capital firm he launched in 2016. Through Refactor Capital, Bilimoria has backed unicorn companies including the green-chemical manufacturer Solugen and the space startup Astranis. AdvertisementTwo years later, Lee stepped down as a general partner — making Bilimoria the firm's sole investor. Life as a solo partnerAs a solo partner, "all the successes and all the challenges are on my shoulders," Bilimoria said. Refactor Capital invests in about eight companies every year and is deploying capital out of its third fund.
Persons: , Bilimoria, Andreessen Horowitz —, weren't, Andreessen Horowitz, David Lee, Lee Organizations: Service, University of Pennsylvania, Business, Microsoft, Netflix, Google, Twitter, Fund, SV Angel Locations: Northwest Indiana
The newly combined company also landed a $17 million Series A led by 7wireVentures. The venture firm is an existing investor in SameSky Health. Health insurance giant Elevance Health, formerly known as Anthem, an existing investor in GroundGame Health, also participated in the round. By addressing these barriers together, GroundGame CEO Susan Rawlings Molina said, GroundGame and SameSky can help more patients access healthcare while saving money for payers. While SameSky's technology can help underserved patients seek out care, GroundGame can close the loop by removing barriers to their access to that care, she said.
Persons: , 7wireVentures, Susan Rawlings Molina, Molina, we're, SameSky, GroundGame, they're, Lee Shapiro, Alyssa Jaffee, Robert Garber, Glen Tullman, haven't, Abner Mason, Garber Organizations: Service, SameSky, Business, Health, 7wireVentures Industry Locations: Health, healthtech, SameSky
VC firm Redesign Health is targeting $250 million in its latest fundraising push. The health-focused investor and accelerator last raised $65 million in September 2022. The health-focused venture firm and startup studio is targeting a $250 million raise, according to three people with knowledge of the efforts. Redesign previously grabbed $250 million for itself and its portfolio companies, including $100 million in Series B funding, in March 2021. Most recently, the firm landed $65 million in Series C funding for itself in September 2022.
Persons: Organizations: Health, Service
Read previewAustin Walters started SpringTide Ventures in 2018 to disrupt healthcare by democratizing access to health innovations. The firm just closed its second $65 million fund to make more of those bets. A tough fundraising environmentAfter closing on its first $20 million fund, which the firm began investing out of in 2019, SpringTide originally set a $100 million target in 2021 for its second fund, Walters said. SpringTide picks a different focus area each time — most recently, home health, where the firm has invested in companies like family primary care startup Nest Health. By solving significant problems with advanced technologies, these companies have natural competitive advantages that allow them to drive outsize returns for the firm, Walters said.
Persons: , Austin Walters, Walters, Henry Ford, We're, SpringTide, Justin Hackworth Photgraphy SpringTide, OpenLoop, outsize, SpringTidew hasn't, " Walters Organizations: Service, SpringTide Ventures, Tiger Global, Sonic Healthcare, Business, Health, Ally Bank, Troomi Wireless Locations: Boston, San Francisco, Salt Lake City, New York
Two Chairs just grabbed $72 million of Series C equity and debt funding led by Amplo. Two Chairs was bringing in $68 million in recurring revenue in December, one source told BI. AdvertisementTalk therapy startup Two Chairs is the latest mental-health player to close on a fresh round of venture funding. The company just raised $72 million in Series C equity and debt funding, led by existing investor Amplo, and including Fifth Down Capital and other unnamed investors. The startup secured the debt funding from Bridge Bank.
Persons: Amplo, Organizations: Service, Fifth Down Capital, Bridge Bank, San Francisco Bay Area, Business Locations: San Francisco Bay, Los Angeles, Seattle, Miami
The frenzy has investors across industries rushing to get into AI deals, including in healthcare. AdvertisementStill, healthcare startups using AI have already raised hundreds of millions of dollars this year, especially to automate tedious administrative tasks for providers and health plans. Andrew Arruda, CEO of Flexpa FlexpaThe AI long-haulNot every startup needs to be an AI startup. AdvertisementPlus, healthcare companies that do want to use AI face higher stakes than other industries, contending with numerous privacy, regulatory, and safety issues, Kong noted. For example — if healthcare AI makes a mistake, could patient health be impacted?
Persons: , Scott Barclay, Nina Achadijan, Shiv Rao Abridge, VCs, nabbed, CodaMetrix, Aike Ho, Christina Farr, Andrew Arruda, that'll, Flexpa, he's, Flexpa's, Kong, Todd Cozzens, it's Organizations: Service, Business, Insight Partners, ACME Capital, nab, Catalyst, HealthQuest, Transformation Locations: Tech, Kong
Read previewAccess Industries, the investment firm founded by billionaire Len Blavatnik that invested in mental health company Cerebral, is suing the company and another of its backers as tensions mount inside the mental health company, according to documents obtained by Business Insider. It's the latest challenge to the once-hot mental health startup, which launched in 2020 to provide mental healthcare online. The lawsuit, filed by Access Industries on April 2 in Delaware, alleges an undercover power grab by WestCap, another Cerebral investor. A sinking shipOnce the hottest and fastest-growing mental health startup, Cerebral's fall from grace has been stunning. Since then, Cerebral hasn't raised any more venture funding, and the mental health company has conducted at least three rounds of layoffs.
Persons: , Len Blavatnik, WestCap, David Mou, SoftBank Organizations: Service, Business, US Department of Justice, Access Industries, DOJ, Industries, Wall Street Journal, Bloomberg, US Drug Enforcement Administration, New York Locations: Delaware, WestCap
Surescripts is up for sale and has hired a bank to search for potential buyers, including private equity firms. The company dominates electronic prescribing, processing 2.5 billion prescriptions in 2023. Surescripts, the healthcare technology company that facilitates most electronic prescribing in the US, is exploring a sale, Business Insider has learned. The privately-held company hired healthcare investment bank TripleTree and is looking for potential buyers, including private equity firms, according to two people with knowledge of the deal. Surescripts, formed by a merger in 2008, has long dominated e-prescribing, providing the connectivity that allows doctors to send prescriptions from their electronic health records to pharmacies.
Persons: Surescripts Organizations: CVS Health, Business
Healthtech startup Pelago just grabbed a fresh round of funding to power its own push. The Series C was an upround for Pelago, said Dr. Yusuf Sherwani, cofounder and CEO. Sherwani said the Series C round may be Pelago's last capital raise before it hopes to IPO. With the Series C funding, Pelago plans to launch a program in the second quarter of the year to refer members who don't complete substance use disorder treatment to inpatient facilities. Check out the 16-slide pitch deck Pelago used to raise a $58 million Series C.
Persons: , Atomico, Yusuf Sherwani, Sherwani, Pelago, Phillips, we've Organizations: Service, Octopus Ventures, Business, Mental Health Services Administration, Healthcare, Centers for Disease Control, MetLife, GE Appliances, Pelago Locations: Pelago
Then, at the Georgia Cancer Center at Augusta University, he began the research that would eventually spin off into his first startup, Georgiamune. The same month, Georgiamune also got FDA clearance to begin human clinical trials for its first cancer drug candidate. Georgiamune's primary drug target works to solve a problem posed by another type of cancer drug on the market, called checkpoint inhibitors. For a Series A biotech startup, Georgiamune has an unusually extensive pipeline, with nine biological targets identified internally, all of which use different mechanisms of action than existing drugs. AdvertisementHere's the 21-slide pitch deck Georgiamune used to raise a $75 million Series A co-led by General Catalyst.
Persons: , Samir Khleif, King, Khleif, Catalyst, CJNV BioVenture, Georgiamune, doesn't, Amy Abernethy, Khleif's, General Catalyst Organizations: Service, King Hussein Cancer Center, Georgia Cancer Center, Augusta University, Business, Parker Institute for Cancer, Mubadala, Alexandria Venture Investments, Catalio Capital Management, Verition Fund Management, Bicara Therapeutics, Therapeutics, General Locations: Jordan, Verily
Read previewLivongo veteran Glen Tullman's latest venture, healthcare startup Trascarent, is raising a Series D round, Business Insider has learned. The sources said the round values Transcarent at about $2.1 billion. Related storiesIt's been a difficult fundraising environment for growth-stage healthcare startups — and that's reflected in Transcarent's latest fundraising push. Transcarent has raised $298 million to date, last grabbing $200 million in a January 2022 Series C round that boosted its valuation to $1.6 billion. Transcarent also acquired 98point6's virtual care platform in March 2023 to offer on-demand telehealth care.
Persons: , Glen Tullman's, General Catalyst, Leslie Krigstein, Transcarent, Tullman, Teladoc, 98point6 Organizations: Service, General, Business, Catalyst, Human, Ally, Group, Alta Partners, Merck Global Health Innovation Fund, Jove Equity, Ventures, GreatPoint Ventures, Intermountain Healthcare, Rush University Medical, Soda Health Locations: Transcarent
But with his latest startup, Cherish Health, he's taking a different approach. To date, Cherish Health, which makes a radar-based device to detect falls in the home, has raised $26 million from these alternative sources. Cherish Health is now gearing up to raise its Series B round, targeting $30 million at a $200 million valuation. In late 2022, Cherish Health landed $5 million in Series A funding led by Alarm.com at a $45 million valuation. If Cherish Health had gone the way of traditional venture capital, Nagpal said, "we would've given up most of our value by now."
Persons: Sumit Nagpal, Nagpal, he's, we've, JP Morgan, Health's, Health, Alarm.com, consortiums, aren't Organizations: pharma, Abbott, Business, Accenture, Health, Apple, Comcast, Amazon, Cherish Health Locations: Alere, Haven, Amazon , Berkshire, Alarm.com, VCs
Reddit went public on Thursday after raising $748 million in its IPO. CEO Steve Huffman and Sam Altman and his network of investment firms are some who profited the most. Reddit is the most recent tech company to debut in the public markets as Wall Street watches to gauge the dormant IPO market. The company, founded in 2005 by Steve Huffman and Alexis Ohanian, had been rumored to go public over the past several years. However, the market has been shaky for the past two years, causing several companies to put off pursuing IPOs because of less-than-desirable macro conditions.
Persons: Reddit, Steve Huffman, Sam Altman, Alexis Ohanian Organizations: Business
Investors aren't anticipating healthcare funding to surge to anything resembling 2021 levels this year, and fewer deals could mean shutdowns for many companies running low on cash. Multiple healthcare startups have announced raises this year at Series B and beyond. Investors said there's now a higher bar for which startups get venture funding compared to 2021, however. Exits and shutdowns aheadWhile a number of biotech startups have jumped into the public markets already this year, the IPO window for healthcare startups has remained firmly shut. Still, many investors are optimistic that a few healthcare startups will test the waters later this year.
Persons: Anargha Vardhana, There's, they're, Christina Farr, haven't, Richard Drury, Scott Barclay, Shiv Rao, Vardhana, there's, Farr, Sara Choi, Ritankar Das, Supriya Jain, Jain, Barclay Organizations: Business, Insight Partners, Investors, Entrepreneurs, Wing Venture Capital, Boston Consulting Locations: orthopedics
download the appSign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. Read previewOnly months after buzzy AI search-engine startup Perplexity AI raised its last round of funding, the company is yet again raising additional funds, as investors clamor to back tech's next big generative AI startup. This story is available exclusively to Business Insider subscribers. Perplexity is raising this additional money at a significantly higher valuation cap than its previous pricing of $520 million, according to two people with direct knowledge. A spokesperson told Business Insider that the details of the deal were incorrect but did not clarify when asked for further information.
Persons: , clamor, Jeff Bezos, Perplexity, OpenAI's ChatGPT, Google's Bard, Aravind Srinivas, It's, Elad Gil, Nat Friedman, Fred Wilson, aren't Organizations: Service, Google, Business, Institutional Venture Partners, New Enterprise Associates, Bessemer Venture Partners, Nvidia Locations: OpenAI
Read previewAxel Bouchon cofounded Matter Neuroscience in 2019 after leading the venture arms of pharma giants Moderna and Bayer. AdvertisementMatter has emerged from stealth with $26 million from ARCH Venture Partners, Polaris Partners, Exor Ventures, and Collaborative Fund, Business Insider has learned exclusively. That $26 million includes an initial seed round led by Polaris Partners and a Series A round led by ARCH Venture Partners. The startup views itself now as a consumer biotech startup, Bouchon said. Here's the 17-slide pitch deck Matter used to raise $26 million.
Persons: , Axel Bouchon, Bouchon Organizations: Service, pharma, Moderna, Bayer, Business, Venture Partners, Polaris Partners, Exor Ventures, Fund, Brain Imaging, Icahn School of Medicine Locations: Maastricht, Netherlands, Mount Sinai, Seoul, South Korea
One Medical's former CEO is making the first investments from his new VC firm, Healthier Capital. The firm has already announced two investments, and Amir Dan Rubin said he's looking for more deals. Amir Dan Rubin announced the launch of his new VC firm, Healthier Capital, in December after capping his six-year stint as CEO of the primary care company One Medical. Healthier Capital announced its first two healthcare investments this month, co-leading a $21 million round for AI-powered medical imaging startup Ezra and backing behavioral health company Octave. Rubin told Business Insider earlier this month the firm was closing a third investment that hasn't yet been announced.
Persons: Amir Dan Rubin, he's, Rubin Organizations: Capital, Business
Read previewWalgreens-backed primary care company VillageMD is closing all its medical clinics in Florida, one of its largest markets. VillageMD confirmed the closures in an email to Business Insider on Wednesday. The closures are part of Walgreens' strategy to slash spending by $1 billion or more as the pharmacy giant's healthcare business struggles with losses. All of the VillageMD clinics in Florida are attached to Walgreens stores, according to Jefferies' January report. At the time of the acquisition, Walgreens had planned to open 1,000 VillageMD clinics located adjacent to its pharmacies by 2027.
Persons: , VillageMD, Jefferies, Tim Wentworth, Brian Tanquilut, Jack Slevin, Tanquilut, Wentworth, Roz Brewer, John Driscoll, Mary Langowski, Driscoll Organizations: Service, Business, Walgreens, Jefferies, CVS Health, Summit, Solera, Shields Health Solutions, Pearl Health Locations: Florida, Texas, Arizona, VillageMD, Houston, Atlanta, Phoenix, Shields
Another AI medical records startup, DeepScribe, raised a $30 million Series A round in January 2022. AbridgeThe investor descent on medical-scribe startups reflects a blatant potential of automation tech to alleviate healthcare’s most critical issues. “This market is screaming hot,” said Bryan Roberts, a partner at Venrock and an investor in medical-scribe startup Suki. AdvertisementStill, as health systems increasingly adopt AI solutions to manage labor costs, these startups have room to grow into their valuations. Medical-scribe startups vying for the remaining slice of the pie are “in a pitch to the death,” Roberts said.
Persons: , , Kleiner Perkins, Andreessen Horowitz, Suki, Punit Soni, Shiv Rao, , Bryan Roberts, ” Roberts, Annie Case, Case, Hermann, Keith Srakocic, Roberts, there’s, Organizations: Service, Business, Healthcare, Fund, Optum Ventures, Medical, Cathay Innovation, Microsoft, University of Pittsburgh Medical Center, University of Kansas Health, AP
The CEO of the VC firm General Catalyst told WSJ that international collaboration will be crucial. World leaders should "align on some core protocols" for AI development, he said. download the app Email address Sign up By clicking “Sign Up”, you accept our Terms of Service and Privacy Policy . Advertisement"Now there's this tension where no country wants to be left behind. So far, Russia has lagged behind China and the US in AI development.
Persons: Catalyst, , Hemant Taneja, Taneja —, Taneja, Joe Biden, it's, Vladimir Putin Organizations: Service, Wall, publication's, US Commerce Department, European Locations: France, India, China, Russia
As healthcare startups dive headfirst into building artificial intelligence products to sell to hospitals, a new report suggests many health systems don't yet have policies to support the tech. In a survey of 34 US health systems leaders, only 16% reported having systemwide policies for AI usage and data access. Some health system leaders said they haven't developed policies because the industry is in the early stages of AI adoption. Many health system leaders surveyed by KLAS expressed excitement about AI software for clinical documentation. Seventy percent of health system leaders surveyed by KLAS said their organizations planned to adopt AI software integrated with their EHRs.
Persons: , hasn't, Robert Califf, KLAS, we'll, Bryan Roberts Organizations: Business, Center, Medicine, UPMC, KLAS Research, Healthcare, Food and Drug Administration, FDA, Venture, University of Pittsburgh Medical Center, University of Kansas Health, Microsoft, Industry
Kindbody, last valued at $1.8 billion, is pitching early-stage investors in its latest fundraising. The startup is offering a discount to investors in the round, according to multiple sources. The fertility company was reportedly burning through cash last year. Kindbody's fundraising push is getting complex as the fertility unicorn dangles discounts to potential investors to secure new cash, Business Insider has learned. Now, Kindbody has been forced to broaden its investor outreach and has pitched multiple early-stage VCs, according to two people with knowledge of the effort.
Persons: Kindbody Organizations: Business, Bloomberg
Read previewLast August, Kim Kardashian posted on Instagram that she'd gotten a full-body MRI scan from the startup Prenuvo, which sparked a national conversation about the merits of preventive imaging. With Kardashian's help, the scans were finally making headlines — and healthtech startup Ezra felt their impact. "The day that Kim Kardashian got a scan, even though it wasn't an Ezra scan, our day-over-day revenue spiked," Ezra CEO and cofounder Emi Gal told Business Insider. Those tailwinds have propelled growth for Ezra, which partners with radiology clinics to perform full-body MRI scans. And, with Ezra's scans, that startup has "helped hundreds of people find cancer," he added.
Persons: , Kim Kardashian, she'd, Ezra, Emi Gal, Amir Dan Rubin, Anne Wojcicki, Vlad Tenev, David Prior, Esther Dyson, — Gal, Ezra Flash, radiologists, Gal, We've Organizations: Service, Business, VC, FirstMark, Firms, Allianz Life Ventures, Mana Ventures, Ventures, Seedcamp, LDV Locations: Gaingels, Republic
AbridgeAbridge CEO Dr. Shiv Rao. AbridgeHQ: PittsburghTotal raised: $62.5 millionWhat it does: The medical scribe startup uses large language models to document patient-doctor interactions in electronic medical records. What makes it promising: Easing administrative burdens for providers is top of mind for investors as growing burnout drives more clinicians out of the healthcare field. Abridge is using AI to tackle one of the most time-consuming, burnout-inducing processes in healthcare — clinical documentation.
Persons: Abridge, Shiv Rao Organizations: Abridge, Pittsburgh
Healthcare staffing startup Nomad Health just slashed its workforce for the third time in a year, Business Insider has learned. The startup, which matches nurses and other clinicians to open jobs in healthcare, cut staff on Wednesday, according to two former employees and more than a dozen LinkedIn posts. The startup previously cut 25% of its nonclinical workforce in October, Business Insider first reported. The following month, nurse staffing startup ConnectRN slashed 20% of its staff, and IntelyCare laid off at least 30 employees. Like most of its medical staffing peers, Nomad Health last raised capital that year, banking $105 million in June 2022.
Persons: Nomad, Maquel Shaw, Shaw, IntelyCare Organizations: Nomad, Business, Forbes
Total: 25